West Pharmaceutical Services Inc. (NYSE:WST) shares hit a new 52-week high on Wednesday . The stock traded as high as $82.00 and last traded at $82.00, with a volume of 113,394 shares. The stock had previously closed at $81.33.

Several brokerages have recently weighed in on WST. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a report on Wednesday, April 20th. Jefferies Group reiterated a “hold” rating and set a $67.00 price objective on shares of West Pharmaceutical Services in a report on Thursday, June 9th. Finally, Janney Montgomery Scott reiterated a “buy” rating and set a $90.00 price objective (up from $69.00) on shares of West Pharmaceutical Services in a report on Friday, May 13th.

The company’s 50-day moving average is $77.64 and its 200-day moving average is $69.98. The firm has a market cap of $5.99 billion and a PE ratio of 59.552.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, July 28th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.56 by $0.03. The firm had revenue of $388 million for the quarter, compared to analyst estimates of $384.58 million. During the same period in the previous year, the firm earned $0.47 earnings per share. West Pharmaceutical Services’s revenue was up 7.9% on a year-over-year basis. Equities research analysts expect that West Pharmaceutical Services Inc. will post $2.23 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 3rd. Investors of record on Wednesday, July 20th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date was Monday, July 18th.

In related news, VP Daniel Malone sold 3,950 shares of West Pharmaceutical Services stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $74.95, for a total value of $296,052.50. Following the transaction, the vice president now owns 30,666 shares of the company’s stock, valued at approximately $2,298,416.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas W. Hofmann sold 2,466 shares of West Pharmaceutical Services stock in a transaction dated Wednesday, May 25th. The stock was sold at an average price of $73.57, for a total value of $181,423.62. Following the completion of the transaction, the director now directly owns 34,506 shares in the company, valued at approximately $2,538,606.42. The disclosure for this sale can be found here.

Other institutional investors recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of West Pharmaceutical Services by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 5,321,348 shares of the company’s stock worth $320,452,000 after buying an additional 46,295 shares in the last quarter. First Trust Advisors LP boosted its position in shares of West Pharmaceutical Services by 104.5% in the fourth quarter. First Trust Advisors LP now owns 24,581 shares of the company’s stock worth $1,480,000 after buying an additional 12,560 shares in the last quarter. GSA Capital Partners LLP boosted its position in shares of West Pharmaceutical Services by 17.9% in the fourth quarter. GSA Capital Partners LLP now owns 17,134 shares of the company’s stock worth $1,032,000 after buying an additional 2,601 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of West Pharmaceutical Services by 0.5% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 20,900 shares of the company’s stock worth $1,259,000 after buying an additional 113 shares in the last quarter. Finally, New York State Common Retirement Fund boosted its position in shares of West Pharmaceutical Services by 3.1% in the fourth quarter. New York State Common Retirement Fund now owns 69,200 shares of the company’s stock worth $4,167,000 after buying an additional 2,100 shares in the last quarter.

West Pharmaceutical Services, Inc is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s products include stoppers and seals for vials, prefillable syringe components and systems, components for intravenous and blood collection systems, safety and administration systems, advanced injection systems, and contract design and manufacturing services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.